Literature DB >> 17283639

Panton-Valentine leukocidin-producing Staphylococcus aureus.

Amos Adler, Violeta Temper, Colin S Block, Nitsa Abramson, Allon E Moses.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17283639      PMCID: PMC3372361          DOI: 10.3201/eid1211.060726

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Panton-Valentine leukocidin (PVL) is a cytotoxin produced by Staphylococcus aureus that causes leukocyte destruction and tissue necrosis (). Although produced by <5% of S. aureus strains, the toxin is detected in large percentages of isolates that cause necrotic skin lesions and severe necrotizing pneumonia (). Although commonly associated with community-acquired methicillin-resistant S. aureus (CA-MRSA) (), several outbreaks due to methicillin-susceptible S. aureus (MSSA) have also been reported (–). We describe an outbreak of cutaneous infections caused by PVL-producing MSSA that affected 6 of 11 members of 2 related families. During a period of 6 months, a cluster of S. aureus skin and soft tissue infections occurred in 2 families in Jerusalem, Israel, that were related through the mothers, who are sisters. The event started with the 4-year-old boy of family A, who had 5 episodes of skin infections, including 2 episodes of perianal abscesses that required drainage and hospitalization. Culture of pus grew MSSA that was resistant to erythromycin and clindamycin. Subsequently, recurrent abscesses and cellulitis developed in the boy's father's legs, and his mother had severe periorbital cellulitis that required hospitalization and surgical drainage. Approximately 1 month later, a 9-year-old boy in family B had severe cellulitis and abscess around his knee that required hospitalization and surgical drainage. Subsequently, infections developed in 2 more children in family B: 1 had a finger pulp-space infection and the other cellulitis of the lower abdomen. All pus cultures grew S. aureus with identical susceptibility patterns. The cases are summarized in the Table.
Table

Clinical and microbiologic data of the outbreak*

No.FamilySex/age (y)Clinical manifestationsPus culturesNasal culturesPFGE pattern/PVL
1AF/33Periorbital cellulitisMSSA, Ery/clin- RMSSA, Ery/clin- RI/P
2AM/36Leg cellulitis/abscessNoneMSSA, Ery/clin- RI/P
3AM/4Perianal abscessMSSA, Ery/clin- RMSSA, Ery/clin- RI/P
4AF/2NoneN
5AF/1NoneN
6BF/37NoneMSSA, Ery/clin-RI/P
7BM/38NoneMSSA, Ery/clin-RI/P
8BM/9Knee cellulitis/abscessMSSA, Ery/clin- RMSSA, Ery/clin- RI/P
9BM/4Finger-pulp infectionNoneMSSA, Ery/clin- SD/N
10BF/3Lower abdomen cellulitisNoneN
11BF/3NoneN

*PFGE, pulsed-field gel electrophoresis; PVL, Panton-Valentine leukocidin; F, female; MSSA, methicillin-sensitive Staphylococcus aureus; Ery, erythromycin; clin, clindamycin; R, resistant; I, identical strain; P, positive; M, male; N, negative; S, sensitive; D, different strain.

*PFGE, pulsed-field gel electrophoresis; PVL, Panton-Valentine leukocidin; F, female; MSSA, methicillin-sensitive Staphylococcus aureus; Ery, erythromycin; clin, clindamycin; R, resistant; I, identical strain; P, positive; M, male; N, negative; S, sensitive; D, different strain. Following these events, the families consulted the infectious diseases clinic at the Hadassah-Hebrew University Medical Center in Jerusalem. Since the clinical isolates were not available, nasal cultures were obtained from all family members. S. aureus was isolated from all the affected members of family A and from the parents and the 2 boys in family B. All 7 isolates were subjected to pulsed-field gel electrophoresis (PFGE) after digestion with SmaI. All except 1 had identical band patterns and the same antimicrobial drug susceptibilities as the clinical isolates. The presence of PVL genes was examined by PCR as previously described () and was detected only in the isolates with identical PFGE patterns. The families were advised to apply mupirocin nasal ointment twice a day for 5 days and to bathe with 4% chlorhexidine scrub for 1 week (). At 7 months of follow-up, no new cases of skin infection had occurred in either family. An epidemiologic investigation was undertaken by the local department of health to determine if 3 kindergartens and 2 schools attended by the 7 children had an increased incidence of staphylococcal skin disease. No evidence of unusual disease was found. We describe here the first confirmed cases of PVL-producing S. aureus infections in Israel. Maier et al () recently described 2 cases of similar infections that occurred in German tourists after visiting the Dead Sea area, but since these infections were caused by MRSA, it is probable that the isolates were genetically distinct from the strain described here. In addition, to the best of our knowledge this is the first description of transmission of PVL-producing MSSA between related families. Previous reports described community-related outbreaks that occurred within families (,,), between schoolmates (), and between football team players (). The exact route of transmission was not identified in some of these cases but it was presumed to have been close contact leading to skin () or nasal () colonization and subsequent active infection. In our report, the PVL-producing S. aureus clone was detected in nasal cultures in 6 of the 11 members of the 2 families. In this niche, it was able to persist and cause a series of infections in a relatively large number of family members. Even though the S. aureus isolated from active lesions were not available for testing, the recovery of identical PVL-positive organisms from nasal cultures strongly suggests the presence of a pathogenic clone that probably caused the recurrent infections in the 6 affected family members. Our investigation highlights the high transmissibility of this PVL-producing S. aureus clone, its high attack rate, and its virulence. The intervention in this outbreak might have prevented not only subsequent recurrences of cutaneous infections but also further spread of this clone and the manifestation of even more serious infections such as necrotizing pneumonia. Increasing awareness among community-based healthcare providers of PVL-producing S. aureus infections is important to facilitate rapid and adequate response in similar clinical events in the future.
  9 in total

1.  Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia.

Authors:  I Le Thomas ; P Mariani-Kurkdjian; A Collignon; A Gravet; O Clermont; N Brahimi; J Gaudelus; Y Aujard; J Navarro; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin.

Authors:  J Maier; H Melzl; U Reischl; I Drubel; W Witte; N Lehn; H Linde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

3.  Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy F Jones; C Buddy Creech; Paul Erwin; Susan G Baird; Amy M Woron; William Schaffner
Journal:  Clin Infect Dis       Date:  2006-03-30       Impact factor: 9.079

4.  Intrafamilial spread of highly virulent staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin.

Authors:  Anders Osterlund; Gunnar Kahlmeter; Lena Bieber; Arne Runehagen; Jan-Michael Breider
Journal:  Scand J Infect Dis       Date:  2002

5.  Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

Authors:  Anne-Laure Genestier; Marie-Cécile Michallet; Gilles Prévost; Gregory Bellot; Lara Chalabreysse; Simone Peyrol; Françoise Thivolet; Jerome Etienne; Gérard Lina; François M Vallette; François Vandenesch; Laurent Genestier
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns.

Authors:  Elizabeth M Begier; Kasia Frenette; Nancy L Barrett; Pat Mshar; Susan Petit; Dave J Boxrud; Kellie Watkins-Colwell; Sheila Wheeler; Elizabeth A Cebelinski; Anita Glennen; Dao Nguyen; James L Hadler
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079

8.  Panton-valentine leukocidin and staphyloccoccal skin infections in schoolchildren.

Authors:  Karim Boubaker; Patrick Diebold; Dominique S Blanc; François Vandenesch; Gérard Praz; Georges Dupuis; Nicolas Troillet
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

9.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

  9 in total
  9 in total

1.  Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller : Proposal for novel treatment indications.

Authors:  Johannes Mischlinger; Heimo Lagler; Nicole Harrison; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2017-08-03       Impact factor: 1.704

2.  Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins.

Authors:  Benoît-Joseph Laventie; Hendrik Jan Rademaker; Maher Saleh; Ernie de Boer; Rick Janssens; Tristan Bourcier; Audrey Subilia; Luc Marcellin; Rien van Haperen; Joyce H G Lebbink; Tao Chen; Gilles Prévost; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

3.  Familial furunculosis associated with community-acquired leukocidin-positive methicillin-susceptible Staphylococcus aureus ST152.

Authors:  E Pérez-Roth; J Alcoba-Flórez; C López-Aguilar; I Gutiérrez-González; B Rivero-Pérez; S Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

Review 4.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Molecular epidemiology of Panton-Valentine Leukocidin-positive community-acquired methicillin resistant Staphylococcus aureus isolates in pastoral communities of rural south western Uganda.

Authors:  Benon B Asiimwe; Rossella Baldan; Alberto Trovato; Daniela M Cirillo
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

Review 6.  Methicillin-resistant Staphylococcus aureus: livestock-associated, antimicrobial, and heavy metal resistance.

Authors:  Cwengile C Dweba; Oliver T Zishiri; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-28       Impact factor: 4.003

Review 7.  Exploring the Role of Staphylococcus aureus in Inflammatory Diseases.

Authors:  Huanquan Chen; Junyan Zhang; Ying He; Zhuoyi Lv; Zhengtong Liang; Jianze Chen; Peishan Li; Jiawei Liu; Hongchen Yang; Ailin Tao; Xueting Liu
Journal:  Toxins (Basel)       Date:  2022-07-06       Impact factor: 5.075

Review 8.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02

9.  Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study.

Authors:  Ali Hassoun; Matthew D Huff; David Weisman; Khushdeep Chahal; Esmeralda Asis; Don Stalons; Elena Grigorenko; Jessica Green; Leslie L Malone; Scott Clemmons; Stanley Lu
Journal:  Am J Infect Control       Date:  2015-06-04       Impact factor: 2.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.